Skip to content
PubMed This is a summary of 16 peer-reviewed journal articles Updated
Pediatric Neurology

Seizure Management & Medical Interventions

At a Glance

Seizure care in CNTNAP2-related DEE is individualized: anti-seizure medicine is usually first, while rescue plans, emergency assessment, a ketogenic diet, vagus nerve stimulation, or surgery may be considered when seizures remain uncontrolled.

Managing seizures in CNTNAP2-related DEE requires a proactive, individualized approach. Because the underlying genetic cause affects how the brain’s “brakes” are positioned, the brain is prone to overactivity [1]. While there is no “one-size-fits-all” medication for this condition, understanding the tools available—and the signs of an emergency—is the foundation of your child’s medical care.

Anti-Seizure Medications (ASMs)

The first line of treatment is typically medication. The goal is to reduce seizure frequency and intensity while minimizing side effects that could interfere with learning and development [2].

  • Variable Response: Some studies show that about two-thirds of children may achieve good seizure control with standard medications [3]. However, others develop pharmacoresistant epilepsy, where seizures continue despite trying multiple medications [4].
  • Commonly Used Drugs: Doctors often use medications standard for focal epilepsy. Your team will monitor for side effects like irritability (common with levetiracetam), cognitive “dulling” or language issues (sometimes seen with topiramate), or general sleepiness [2][5]. Importantly, anti-seizure medications must never be stopped abruptly, as this can trigger severe withdrawal seizures.
  • Symptomatic Treatment: Currently, there are no gene-specific “precision” drugs for this condition. Treatment focuses on managing the symptoms as they appear [6].

Emergency Red Flags: Status Epilepticus

An epilepsy emergency, known as status epilepticus, occurs when a seizure lasts too long or when multiple seizures happen so close together that the child does not fully recover in between [7]. Every caregiver should have a written Seizure Action Plan. Basic seizure first aid includes: 1) Time the seizure. 2) Protect from injury. 3) Place the child on their side when convulsions subside. 4) Do not restrain or put anything in their mouth. 5) Do not give oral medication while unresponsive. 6) Follow the prescribed rescue-medication plan.

Type What it Looks Like Action Required
Convulsive Status Continuous “grand mal” shaking or stiffening [8]. Follow your Seizure Action Plan. Administer rescue medication (like midazolam or diazepam) at the pre-set time (often 5 minutes) [9].
Non-Convulsive Status (NCSE) A “mental fog” that doesn’t lift. Your child may seem unusually confused, lethargic, or “not there” for a prolonged period [10]. This is harder to spot. If there is new or prolonged altered awareness, a failure to return toward baseline, or an acute deterioration in responsiveness, seek emergency assessment, as NCSE is diagnosed and managed urgently with EEG monitoring [11].

When to Call 911/Emergency Services:

  • A convulsive seizure lasts longer than 5 minutes (or as specified in your plan).
  • A second seizure starts before the child has fully recovered from the first.
  • The child has difficulty breathing or changes color during or after the seizure.
  • The seizure occurs in water (like a bathtub or pool).

The Role and Limits of Surgery

In some forms of focal epilepsy, surgeons can remove the specific “misfiring” part of the brain to stop seizures. While children with CNTNAP2-related DEE may be less likely to have a single resectable focus due to bilateral or broader network involvement [12], they should still be evaluated at a comprehensive epilepsy center [4].

  • Bilateral Involvement: Even if an MRI shows an abnormality in one temporal lobe, the genetic nature of the condition means the entire brain network is affected. Seizures often start independently in both the left and right temporal lobes [4].
  • Surgical Options: Depending on the individual’s EEG, MRI, and seizure network, specialists may consider resection, ablation, or palliative procedures, although reports have shown that even when surgeons remove a visible area of cortical dysplasia, the seizures often return because the “misfiring” network is more widespread than what can be seen on a scan [12][13].

Beyond Medications: Other Interventions

If medications are not providing enough control, your team may discuss other medical interventions used in complex DEEs:

  • Ketogenic Diet: A specialized, high-fat medical diet that can help stabilize brain activity in some children with drug-resistant epilepsy. It requires strict medical screening and supervision by an epilepsy dietitian [14].
  • Vagus Nerve Stimulation (VNS): A small device implanted under the skin that sends regular electrical pulses to the brain to help dampen seizure activity [15].
  • Routine Monitoring: It is vital to track not just seizures, but also developmental progress and medication side effects. Changes in sleep, appetite, or mood should be shared with your neurologist, as these impacts on quality of life are just as important as the seizure count itself [16][2].

Common questions in this guide

What treatments are used for seizures in CNTNAP2-related DEE?
Anti-seizure medicines are usually the first treatment, and doctors adjust them to balance seizure control with effects on alertness, language, mood, and sleep. Some children respond well, while others develop drug-resistant epilepsy. There is currently no gene-specific medicine for CNTNAP2-related DEE, so care is based on the child's symptoms and response.
When should I give rescue medicine or call emergency services for a seizure?
Follow the child's written Seizure Action Plan; many plans instruct caregivers to give rescue medicine when a convulsive seizure reaches 5 minutes, but the prescribed timing takes priority. Call emergency services if the seizure continues, another begins before recovery, breathing or color changes, or the seizure occurs in water. Do not give anything by mouth while the child is unresponsive.
How can I recognize non-convulsive status epilepticus?
It may look like prolonged confusion, unusual sleepiness, reduced responsiveness, or a child who does not return toward their usual baseline rather than visible shaking. New or persistent altered awareness needs urgent medical assessment because an EEG may be needed to confirm and treat it. Caregivers should use the child's baseline behavior and action plan when deciding how to respond.
Can epilepsy surgery help a child with CNTNAP2-related DEE?
Some children may be evaluated for resection, ablation, or a palliative procedure at a comprehensive epilepsy center. CNTNAP2-related DEE can involve seizure networks on both sides of the brain, so removing one visible abnormal area may not stop seizures permanently. EEG, MRI, and the overall seizure pattern guide the decision.
When might a ketogenic diet or VNS be considered?
A ketogenic diet or vagus nerve stimulation (VNS) may be discussed when seizures are not adequately controlled with medicines, especially in drug-resistant epilepsy. The ketogenic diet requires medical screening and close supervision by an epilepsy dietitian, while VNS requires implantation of a small device. These options are individualized and do not replace specialist care.
Should anti-seizure medicine ever be stopped suddenly?
No. Stopping an anti-seizure medicine abruptly can trigger severe withdrawal seizures. If irritability, sleepiness, language changes, mood changes, appetite changes, or coordination problems appear after a dose change, contact the neurologist before changing the dose.
What should a seizure action plan and seizure log include?
The plan should be written and available to family members, school staff, and therapists, with first-aid steps, rescue-medicine timing, and emergency thresholds. A seizure log should record what happened, how long the seizure lasted, and how long recovery took, along with medication effects and relevant changes in sleep, mood, or appetite. Share these records with the neurologist.

Get notified when new evidence is published on CNTNAP2-related developmental and epileptic encephalopathy.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (16)
  1. 1

    CNTNAP2 in neurodevelopmental disorders: Genetics, excitation/inhibition mechanisms and preclinical evidence.

    Dhungel A, Bora R, Chamidah AN, Menge DM

    Molecular and cellular neurosciences 2026; (139()):104127 doi:10.1016/j.mcn.2026.104127.

    PMID: 42815598
  2. 2

    Psychobehavioural and Cognitive Adverse Events of Anti-Seizure Medications for the Treatment of Developmental and Epileptic Encephalopathies.

    Strzelczyk A, Schubert-Bast S

    CNS drugs 2022; (36(10)):1079-1111 doi:10.1007/s40263-022-00955-9.

    PMID: 36194365
  3. 3

    Genotype-phenotype correlation in contactin-associated protein-like 2 (CNTNAP-2) developmental disorder.

    D'Onofrio G, Accogli A, Severino M, et al.

    Human genetics 2023; (142(7)):909-925 doi:10.1007/s00439-023-02552-2.

    PMID: 37183190
  4. 4

    Bilateral temporal lobe dysplasia and seizure onset associated with biallelic CNTNAP2 variants.

    Panza N, Bianchini C, Cetica V, et al.

    Epilepsia open 2024; (9(1)):417-423 doi:10.1002/epi4.12843.

    PMID: 37805811
  5. 5

    A Practical Guide to the Treatment of Dravet Syndrome with Anti-Seizure Medication.

    Strzelczyk A, Schubert-Bast S

    CNS drugs 2022; (36(3)):217-237 doi:10.1007/s40263-022-00898-1.

    PMID: 35156171
  6. 6

    Precision Medicine Approaches for Infantile-Onset Developmental and Epileptic Encephalopathies.

    Myers KA, Scheffer IE

    Annual review of pharmacology and toxicology 2022; (62()):641-662 doi:10.1146/annurev-pharmtox-052120-084449.

    PMID: 34579535
  7. 7

    Defining Dravet syndrome: An essential pre-requisite for precision medicine trials.

    Li W, Schneider AL, Scheffer IE

    Epilepsia 2021; (62(9)):2205-2217 doi:10.1111/epi.17015.

    PMID: 34338318
  8. 8

    Rates of Status Epilepticus and Sudden Unexplained Death in Epilepsy in People With Genetic Developmental and Epileptic Encephalopathies.

    Donnan AM, Schneider AL, Russ-Hall S, et al.

    Neurology 2023; (100(16)):e1712-e1722 doi:10.1212/WNL.0000000000207080.

    PMID: 36750385
  9. 9

    Practical consensus recommendations for polytherapy involving stiripentol in Dravet syndrome: A nominal group approach.

    Cross JH, Nabbout R, Gidal B, et al.

    Epilepsia open 2026; (11(3)):833-846 doi:10.1002/epi4.70245.

    PMID: 41848774
  10. 10

    Nonconvulsive status epilepticus in epileptic encephalopathies in childhood.

    Hamad AP, Ferrari-Marinho T, Caboclo LO, et al.

    Seizure 2020; (80()):212-220 doi:10.1016/j.seizure.2020.06.024.

    PMID: 32645639
  11. 11

    Overview of clinical and physiologic aspects of status epilepticus in the developmental and epileptic encephalopathies.

    Wirrell EC

    Epilepsy & behavior : E&B 2024; (159()):109950 doi:10.1016/j.yebeh.2024.109950.

    PMID: 39067356
  12. 12

    Exploring the clinical spectrum of CNTNAP2-related neurodevelopmental disorders: A case series and a literature appraisal.

    Barcia G, Scorrano G, Rio M, et al.

    European journal of medical genetics 2024; (72()):104979 doi:10.1016/j.ejmg.2024.104979.

    PMID: 39423951
  13. 13

    Technical Neurosurgical Aspects of Pediatric Epilepsy Surgery Including Resections and Disconnections.

    Botros D, Warsi NM, Bollo RJ

    Pediatric neurosurgery 2026; (61(1)):49-55 doi:10.1159/000549430.

    PMID: 41231745
  14. 14

    Add-on ketogenic diet versus antiseizure medications alone in children with developmental and epileptic encephalopathies: a prospective comparative cohort study.

    Hu W, Li L, Zhao F, et al.

    Frontiers in neurology 2025; (16()):1677046 doi:10.3389/fneur.2025.1677046.

    PMID: 41127284
  15. 15

    Vagus nerve stimulation for treating developmental and epileptic encephalopathy in young children.

    Geng G, Hu W, Meng Y, et al.

    Frontiers in neurology 2023; (14()):1191831 doi:10.3389/fneur.2023.1191831.

    PMID: 37928141
  16. 16

    Beyond seizures: proceedings of the ERN EpiCARE working group 18 on developmental and epileptic encephalopathies.

    De Giorgis V, Dalla Bernardina B, Brambilla I, et al.

    Epilepsy & behavior : E&B 2026; (182()):111112 doi:10.1016/j.yebeh.2026.111112.

    PMID: 42161158

This page explains seizure treatment and emergency planning for CNTNAP2-related DEE for informational purposes only and does not replace medical advice. Follow your child's individualized Seizure Action Plan and contact the treating neurologist or emergency services when needed.